Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.04
15% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $616.3K | $424.8K | $0 | $0 | $12.0K | $12.0K | $12.0K | $0 |
| Cost of revenue | $3.3K | $2.1M | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $613.0K | −$1.7M | $0 | $0 | $12.0K | $12.0K | $12.0K | $0 |
| Gross margin | 99.5% | -400.5% | — | — | 100.0% | 100.0% | 100.0% | — |
| R&D | $639.9K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$5.7M | −$4.9M | −$230.0K | −$495.5K | −$422.0K | −$3.5M | −$928.0K | −$238.8K |
| EBITDA | −$5.6M | $6.5M | $0 | −$495.5K | $310.4K | −$3.1M | −$1.8M | −$238.8K |
| Net income | $10.4M | $6.3M | −$545.0K | −$1.4M | −$766.0K | −$4.2M | −$3.2M | $2.4M |
| Net margin | 1689.0% | 1472.2% | — | — | -6383.3% | -34891.7% | -26941.7% | — |
| EPS (diluted) | 0.45 | 0.28 | -0.01 | -0.03 | -0.02 | -0.09 | -0.07 | 0.05 |
Annual figures · source: Financial Modeling Prep
NOVELSTEM INTL CORP
No one on the platform currently holds NSTM.
No tracked institution reports a position in NSTM as of their last filing.
No one on the platform has traded NSTM yet.
| $165839 |
| — |
| DTRKDATATRAK International, Inc. | $0.18 | +0.00% | $230040 | — |
| EPGNFEpigenomics AG | $1.12 | +0.00% | $982212 | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 67.7× sales vs its 694.1× historical median P/S.
Fair value ≈ $0.13 · price $0.01 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$NSTM: NovelStem Announces Material Developments and Strategic Repositioning of the Company. #OTC #Stocks https://www.globenewswire.com/news-release/2025/05/20/3084861/0/en/NovelStem-Announces-Material-Developments-and-Strategic-Repositioning-of-the-Company.html
View on StockTwits ↗NovelStem International Corp. Files SEC Form 10-Q $NSTM https://www.marketbeat.com/stocks/OTCMKTS/NSTM/sec-filings/
View on StockTwits ↗NovelStem International Corp. Files SEC Form 10-Q $NSTM https://www.marketbeat.com/stocks/OTCMKTS/NSTM/sec-filings/
View on StockTwits ↗Gyrodyne Appoints Jan Loeb to its Board $GYRO owns/manages a diversified real estate portfolio of office, industrial & service-oriented properties in the New York metro area. Jan is CEO of $ACFN and Chairman of $NSTM https://www.businesswire.com/news/home/20230801880027/en/Gyrodyne-Appoints-Jan-Loeb-to-Board-of-Directors
View on StockTwits ↗$NSTM: Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising; proceeds will fund stem-cell platform development. #books #cybercrime #entertainment #microcaps #animation #arbitration #gaming #streaming #merchandising #NetForce #ComputerCrime #espionage #TomClancyNetForce #enovella #novella https://www.newsfilecorp.com/release/173428/Arbitration-Confirms-NovelStem-Joint-Ventures-Rights-to-Exploit-Tom-Clancys-Net-Force-Franchise-Globally-via-Film-TV-Online-Streaming-Gaming-and-Merchandising
View on StockTwits ↗NovelStem International Corp. Files SEC Form 8-K $NSTM https://www.marketbeat.com/stocks/OTCMKTS/NSTM/sec-filings/
View on StockTwits ↗https://www.newsfilecorp.com/release/173428 $NSTM Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force'
View on StockTwits ↗NovelStem International Sees Short Interest Decrease from 300 shares to 100 shares. $NSTM https://www.marketbeat.com/stocks/OTCMKTS/NSTM/sh
View on StockTwits ↗$NSTM [15s. delayed] filed form 10-12G/A on June 28, 14:46:54 https://s.flashalert.me/ZxSD6Y
View on StockTwits ↗$NSTM: Our Form 10-Q for the first quarter ended March 31, 2023, as well as our 10-K for 2022 are located here: https://www.sec.gov/edgar/browse/?CIK=912544&owner=exclude
View on StockTwits ↗NovelStem International Corp. Files SEC Form 10-Q $NSTM https://www.marketbeat.com/stocks/OTCMKTS/NSTM/sec-filings/
View on StockTwits ↗$NSTM [15s. delayed] filed form 10-Q on May 12, 15:38:15 https://s.flashalert.me/yffuIl
View on StockTwits ↗$NSTM [15s. delayed] filed form 10-K on March 31, 14:44:16 https://s.flashalert.me/DoD5rS
View on StockTwits ↗$NSTM [15s. delayed] filed form 10-12G/A on January 26, 10:09:09 https://s.flashalert.me/8ffSEF
View on StockTwits ↗$NSTM Form 10-12G/A (registration of securities [section 12(g)]) filed with the SEC https://newsfilter.io/a/aacb86541b03e65733bb8f3c88d2e85d
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.